Wyeth Ilaclari As
⚠️ Moderate Risk
FEI: 3003669791 • Esentepe Istanbul • TURKEY
FEI Number
3003669791
Location
Esentepe Istanbul
Country
TURKEYAddress
Maya Akar Ctr, , Esentepe Istanbul, , Turkey
Moderate Risk
FDA Import Risk Assessment
This firm has a moderate history of FDA import refusals. Some attention may be warranted.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
NO PMA
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 6/18/2004 | 60LCA99ANALGESIC, N.E.C. | New York District Office (NYK-DO) | |
| 6/18/2004 | 60LCA80ERGOTAMINE TARTRATE (ANALGESIC) | New York District Office (NYK-DO) | |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 11/26/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | 472NO ENGLISH | New York District Office (NYK-DO) |
| 10/24/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | Cincinnati District Office (CIN-DO) | |
| 10/8/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | Cincinnati District Office (CIN-DO) | |
| 10/8/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | Cincinnati District Office (CIN-DO) | |
| 10/8/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | Cincinnati District Office (CIN-DO) | |
| 10/8/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | Cincinnati District Office (CIN-DO) | |
| 10/8/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | Cincinnati District Office (CIN-DO) | |
| 10/8/2002 | 89MOZACID, HYALURONIC, INTRAARTICULAR | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is Wyeth Ilaclari As's FDA import refusal history?
Wyeth Ilaclari As (FEI: 3003669791) has 40 FDA import refusal record(s) in our database, spanning from 10/8/2002 to 6/18/2004.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Wyeth Ilaclari As's FEI number is 3003669791.
What types of violations has Wyeth Ilaclari As received?
Wyeth Ilaclari As has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Wyeth Ilaclari As come from?
All FDA import refusal data for Wyeth Ilaclari As is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.